|本期目录/Table of Contents|

[1]高彦青,周蕾,侯候,等.血清钙卫蛋白与类风湿关节炎活动度相关性的临床研究[J].天津医科大学学报,2018,24(03):226-228.
　GAO Yan-qing,ZHOU Lei,HOU Hou,et al.Clinical study on the correlation between serum calprotectin levels and rheumatoid arthritis[J].Journal of Tianjin Medical University,2018,24(03):226-228.
点击复制

血清钙卫蛋白与类风湿关节炎活动度相关性的临床研究(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
24卷
期数:
2018年03期
页码:
226-228
栏目:
出版日期:
2018-05-20

文章信息/Info

Title:
Clinical study on the correlation between serum calprotectin levels and rheumatoid arthritis
作者:
高彦青; 周蕾; 侯候; 赵冕; 朱桂晋; 靳永欣
天津医科大学总医院风湿免疫科，天津 300052
Author(s):
GAO Yan-qing;  ZHOU Lei;  HOU Hou;  ZHAO Mian;  ZHU Gui-jin;  JIN Yong-xin
Department of Rheumatology and Immunology, General Hospital, Tianjin Medical University, Tianjin 300052，China
关键词:
关节炎; 类风湿; 钙卫蛋白; 疾病活动度
Keywords:
arthritis;  rheumatoid;  calprotectin;  disease activity
分类号:
R593.22
DOI:
-
文献标志码:
A
摘要:
目的：探讨血清钙卫蛋白（S100A8/A9）水平与类风湿关节炎(RA)疾病活动度的关系。方法：选取类风湿关节炎患者55例，健康志愿者25例，RA患者依据病情活动度分为活动组34例，缓解组21例。采用ELISA检测血清中钙卫蛋白水平，比较RA患者与健康者及RA活动组与缓解组间的血清钙卫蛋白水平差异，并分析RA患者血清钙卫蛋白水平与临床指标的相关性。结果：RA患者组血清钙卫蛋白水平高于健康对照组[（251.38±48.72） pg/mL vs （216.53±40.95） pg/mL，P＜0.01]；RA活动组血清钙卫蛋白水平高于缓解组[( 278.75±37.80) pg/mL vs （207.07±26.77） pg/mL，P＜0.01]。RA患者血清钙卫蛋白水平与血沉、C反应蛋白、血小板、免疫球蛋白G、疾病活动度指数28评分、肿胀关节计数、压痛关节计数呈正相关。结论：RA患者血清钙卫蛋白水平高于健康人，异常升高的血清钙卫蛋白水平DAS与RA患者的疾病活动度相关，可能成为评价疾病活动的指标之一。
Abstract:
Objective: To investigate the relationship between serum calprotectin (S100A8/A9) and the activity of rheumatoid arthritis (RA). Methods: Fifty-five patients with RA and 25 healthy volunteers were enrolled in this study. The patients were assigned into two groups: active group (n = 34) and remission group (n = 21). Serum levels of calprotectin were measured by ELISA. The serum calprotectin levels of RA patients and healthy group, active group and remission group were compared. The correlations between serum protein level and clinical indices were also analyzed. Results: The level of serum calprotectin in RA patients was higher than that in healthy controls [(251.38 ± 48.72) pg / mL vs (216.53 ± 40.95) pg/mL, P <0.01)]; the level of serum calprotectin in active group was higher than that in remission group [(278.75 ± 37.80) pg / mL vs(207.07 ± 26.77) pg / mL, P<0.01]. The level of serum calprotectin in RA patients was positively correlated with ESR, C-reactive protein, platelet, immunoglobulin G, DAS28 score, swollen joint count and tender joint count. Conclusion: The level of serum calprotectin in RA patients is higher than that in healthy people. The abnormally elevated serum calprotectin level is associated with disease activity of RA patients, which may be one of the indicators to evaluate disease activity.

参考文献/References:

[1] Andrés Cerezo L, Mann H, Pecha O, et al. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis[J]. Arthritis Res Ther, 2011, 13(4): R122
[2] Prevoo M L, Van’t Hof M A, Kuper H H, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis[J]. Arthritis Rheum, 1995, 38(1): 44
[3] Kopeé-M?誰drek M, Widuchowska M, Kucharz E J. Calprotectin in rheumatic diseases: a review[J]. Reumatologia, 2016, 54(6): 306
[4] Bae S C, Lee Y H. Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis[J]. Postgrad Med, 2017, 129(5): 531
[5] Malemud C J. Myeloid-related protein activity in rheumatoid arthritis[J]. Int J Inflam, 2011 ,2011: 580295
[6] Pruenster M, Vogl T, Roth J, et al. S100A8/A9: from basic science to clinical application[J]. Pharmacol Ther, 2016, 167: 120
[7] Hammer H B, Odegard S, Fagerhol M K, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis[J]. Ann Rheum Dis, 2007, 66(8): 1093
[8] Choi I Y, Gerlag D M, Herenius M J, et al. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2015, 74(3): 499
[9] Hurnakova J, Hulejova H, Zavada J, et al. Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study[J]. PLoS One, 2017, 12(8): e0183420
[10] Choi I Y, Gerlag D M, Holzinger D, et al. From synovial tissue to peripheral blood: myeloid related protein 8/14 is a sensitive biomarker for effective treatment in early drug development in patients with rheumatoid arthritis[J]. PLoS One, 2014, 9(8): e106253

相似文献/References:

备注/Memo

备注/Memo:
文章编号 1006-8147(2018)03-0226-03
作者简介 高彦青（1991-），女，硕士在读，研究方向：风湿病学；通信作者：周蕾，E-mail： yizhe1234@126.com。
更新日期/Last Update: 2018-05-20